A drug with the SMILES CCCCN1CC(=O)N2[C@H](c3ccc(OC)cc3)[C@@H]3C(=O)N(CC)C(=O)[C@@H]3[C@]2(C)C1=O has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -2.876%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCCCN1CC(=O)N2[C@H](c3ccc(OC)cc3)[C@@H]3C(=O)N(CC)C(=O)[C@@H]3[C@]2(C)C1=O
CCCCN1CC(=O)N2[C@H](c3ccc(OC)cc3)[C@@H]3C(=O)N(CC)C(=O)[C@@H]3[C@]2(C)C1=O
(1R,2S,6R,7S)-11-butyl-4-ethyl-7-(4-methoxyphenyl)-1-methyl-4,8,11-triazatricyclo[6.4.0.02,6]dodecane-3,5,9,12-tetrone